Search results for “Hemoglobinuria” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 60 patents, we discovered top 16 key players by total patent application. Alnylam Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., Enzon Pharmaceuticals, Inc. are dominant in this area. They take 40.00% of the total patent filing.
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 8
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 8
Enzon Pharmaceuticals, Inc.
New Jersey, United States
Patent: 8
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 7
Omeros Corp.
Washington, United States
Patent: 4
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 4
Kyowa Hakko Bio Co., Ltd.
Tokyo-to, Japan
Patent: 4
Alexion Cambridge Corp.
Massachusetts, United States
Patent: 2
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 26 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing BioCryst Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd. take 65.38% of patent filing during this period.
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 8
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 5
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 4
Xinac (Beijing) Biochemical Marker Detection Medical Research Co., Ltd.
Beijing Shi, China
Patent: 1
Apellis Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
Ra Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 1
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 26 patents in last 5 years, we discover 6 new entrants. BioCryst Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Xinac (Beijing) Biochemical Marker Detection Medical Research Co., Ltd. are the most active new entrants in this area.
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 8
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 4
Xinac (Beijing) Biochemical Marker Detection Medical Research Co., Ltd.
Beijing Shi, China
Patent: 1
Apellis Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
Ra Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 7 patents, we discovered top 1 universities and scientific research institutions by total patent application.
University of Leicester
LEICESTER, United Kingdom
Patent: 4
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: